Data as of Dec 12
| -0.05 / -0.33%|
ANI Pharmaceuticals, Inc. is a pharmaceutical company which develops, manufactures and markets prescription pharmaceuticals in the U.S. The company focuses on developing products for female sexual health, menopause, contraception and male hypogonadism. Its products include LibiGel, a transdermal testosterone gel, which is used for the treatment of female sexual dysfunction, specifically hypoactive sexual desire disorder; Testosterone Gel for Men, which is used for the treatment of hypogonadism, or testosterone deficiency in men; The Pill-Plus, which is used for various combinations of estrogens, progestogens and androgens; and Elestrin, a transdermal estradiol gel, which is used for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
|Arthur S. Przybyl||President, Chief Executive Officer & Director|
|James G. Marken||Vice President-Operations|
|Charlotte C. Arnold||Chief Financial Officer, Secretary, Treasurer & VP|
|Joanne Zborowski||Vice President-Clinical Development|
|Patricia Fuller||Vice President-Information Technology|